Publications

2014
17 March

EU Regulation on Clinical Trials – Close to the Finish Line
12 March

Corporate Interests Should Not Trump Access to Medicines for EU Citizens in Secret TTIP Negotiations
3 March

2013 Annual Report and Financial Statements
1 March

2013 Annual Report and Financial Statements
1 February

Working Paper 4 – Competition Policy
1 February

Policy Brief 3 – Regulation of Mark-ups in the Pharmaceutical Supply Chain
1 February

Policy Brief 6 – The Role of Health Technology Assessment in Medicine Pricing and Reimbursement
1 February

Policy Brief 5 – Sales Taxes on Medicines
1 February

Policy Brief 2 – The Role of Health Insurance in the Cost-effective Use of Medicines
1 February

Working Paper 1 – External Reference Pricing
1 February

Working Paper 6 – The Role of Health Technology Assessment in Medicine Pricing and Reimbursement
1 February

Policy Brief 4 – Competition Policy
1 February

Policy Brief 1 – External Reference Pricing
1 February

Working Paper 2 – The Role of Health Insurance in the Cost-Effective Use of Medicines
1 February

Working Paper 3: The Regulation of Mark-ups in the Pharmaceutical Supply Chain
1 February

Working Paper 5 – Sales Taxes on Medicines
1 January

Understanding and Responding To Medicines Promotion
2013
1 December

The Status Quo Wins Again: Selected R&D Demonstration Projects Disappoint, Offer Little Progress (2013)
11 October

EU Regulation on Clinical Trials: Further enhance clinical data transparency
6 October

Transparency of Clinical Trial Data on Medicines in the EU
27 September

Transparency in the Public Interest: How the EMA Policy on Publication and Access to Cinical-trial Data Could Help Save Lives
20 September

Trade, TRIPS+, & Access to Medicines
18 September

EU-Thailand Free Trade Agreement: Not at the expense of access to medicines
25 July

HAI Europe Calls on EFPIA and PhRMA to Truly Commit to Clinical Trial Data Transparency
1 July

LAC-Global Alliance Statement on Trans-Pacific Partnership and Access to Affordable Medicines
21 June

NGOs Condemn the EU Press Release on TRIPS Extension for Least Developed Countries
17 June

Long-awaited Steps Towards Affordable Access and Needs-driven Research and Development
16 April

Comprendre la promotion pharmaceutique et y répondre: Un manuel pratique
9 April

EU-India free trade deal puts millions of lives at risk
1 April

La Alianza LAC-Global reconoce el paso dado por el Medicines Patent Pool